<SEC-DOCUMENT>0001437749-20-007269.txt : 20200407
<SEC-HEADER>0001437749-20-007269.hdr.sgml : 20200407
<ACCEPTANCE-DATETIME>20200407163149
ACCESSION NUMBER:		0001437749-20-007269
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200403
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200407
DATE AS OF CHANGE:		20200407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		20780074

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		7323591100

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING A, SUITE E
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi20200407_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html><head>
	<title>bkyi20200407_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 4/7/2020 6:37:30 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>UNITED STATES</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Washington, D.C. 20549</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;text-indent:4.5pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>FORM 8-K</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Date of Report (Date of earliest event reported): April 3, 2020</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt 7.2pt;text-align:center;"><b>BIO-key International, Inc.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">(Exact name of registrant as specified in its charter)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:center;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tr>
			<td style="vertical-align:top;width:33%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Delaware</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(State or other jurisdiction of incorporation)</p>
			</td>
			<td style="vertical-align:top;width:34%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>00</b><b>1-13463</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Commission File Number)</p>
			</td>
			<td style="vertical-align:top;width:33%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>41-1741861</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(I.R.S. Employer Identification No.)</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>3349 Highway 138, Building A, Suite E</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Wall, NJ 07719</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Address of principal executive offices)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(732)&nbsp;359-1100</b></p>

			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Registrant&#8217;s telephone number, including area code)</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tr>
			<td style="vertical-align: top; border-color: rgb(0, 0, 0); border-style: solid; border-width: 1px; width: 25.8%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Title of each class</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 25.5%; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Trading Symbol(s)</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 48.7%; border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Name of each exchange on which registered</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 25.8%; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Common Stock</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 25.5%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">BKYI&nbsp;</p>
			</td>
			<td style="vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); width: 48.7%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Nasdaq&nbsp;Capital Market</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2 below):</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744;&nbsp; &nbsp; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744;&nbsp; &nbsp; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744;&nbsp; &nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&#9744;&nbsp;&nbsp;&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Emerging growth company &#9744;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Item 5.02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On April 3, 2020, Manny Alia was appointed to serve on the Board of Directors (the &#8220;Board&#8221;) of BIO-key International, Inc. (the &#8220;Company&#8221;). We have not yet determined which committees of the Board, if any, Mr. Alia will serve as a member of.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Mr. Alia has over fifteen (15) years of experience in advising companies in the financial and banking industries. Since July 2019, he has served as the President of Exponential Launch Partners LLC, a corporate development, advisory and investment firm. Mr. Alia is also the Chief Executive Officer of Technology Transfer Institute (&#8220;TTI&#8221;), a company specializing in the delivery of technology solutions, since its establishment in 2019. From 2011 through 2019, Mr. Alia served as an Executive Director at JP Morgan Bank (&#8220;JP Morgan&#8221;) specializing in the financial and banking services industries and opportunities in Africa. Prior to serving as an Executive Director at JP Morgan, Mr. Alia served as Head of Wholesale Operations of JP Morgan&#8217;s Corporate and Investment Banking in the U.S. and Canada from 2007 through 2011. Mr. Alia received Bachelor of Arts in Accounting from SouthEastern University and a Master&#8217;s of Business Administration (MBA) from Cornell University.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Mr. Alia&#8217;s business acumen, financial experience, and network of relationships, particularly in Africa, strengthens the Board&#8217;s collective qualifications, skills, and experience as the Company&#8217;s business continues to grow and expand in Africa.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As previously disclosed in the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 31, 2020, the Company recently entered into a sales incentive agreement (the &#8220;Sales Agreement&#8221;) with TTI, a company in which Mr. Alia is the Chief Executive Officer, to pursue market opportunities in the continent of Africa.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">There are no arrangements or understandings between Mr. Alia and any other persons pursuant to which Mr. Alia was selected as a director of the Company. Aside from the Sales Agreement, there are no relationships or related transactions between Mr. Alia and the Company that would be required to be reported.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Events</b></p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On April 7, 2020, the Chairman and Chief Executive Officer of the Company issued a letter to the Company&#8217;s partners, customers and shareholders in the form of a press release (the &#8220;Letter&#8221;). The Letter provides certain information regarding the Company&#8217;s operations and recent developments and provides other business updates. A copy of the Letter is included as Exhibit 99.1 and incorporated by reference herein.</p>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</b></p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 36pt; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">(d)&nbsp;</p>
			</td>
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">Exhibits</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 36pt; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>
			</td>
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 36pt; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">99.1</p>
			</td>
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;"><a href="ex_180384.htm" style="-sec-extract:exhibit;">Letter to partners, customers and shareholders, dated April 7, 2020, issued by&nbsp;the Chairman and CEO of BIO-key International, Inc.</a></p>
			</td>
		</tr>

</table>

<p style="background-color: rgb(255, 255, 255); font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="background-color:#FFFFFF;font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURES</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td colspan="2" style="vertical-align:top;width:38%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">BIO-key International, Inc.</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:bottom;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Date: April 7, 2020</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">By:</p>
			</td>
			<td style="vertical-align:top;border-bottom:solid 1px #000000;;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><i>/s/&nbsp;&nbsp;Cecilia Welch</i></p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Cecilia Welch</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:53%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:3.1%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:35%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Chief Financial Officer</p>
			</td>
			<td style="vertical-align:top;width:9%;">
			<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_180384.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_180384.htm</title>

	<!-- Generated by ThunderDome Portal - 4/7/2020 4:51:27 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><img src="ex_180384img001.jpg" style="width: 166pt; height: 41pt;"></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>BIO-key Chairman &amp; CEO Provides Operational Update </b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>Regarding Company&#8217;s Biometric Authentication Solutions Business</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>&nbsp;</i></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Wall</b><b>, New Jersey</b> &#8211; April 7, 2020 - <u><b>BIO-key International, Inc.</b></u> (Nasdaq: BKYI), an innovative provider of biometric software and hardware solutions for strong, convenient user authentication and large-scale identity, today provided an update message for customers, partners and investors from its Chairman &amp; CEO Michael DePasquale, regarding its operations in the current environment.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Chairman &amp; CEO&#8217;s </b><b>Message</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">For many, adjusting to the circumstances caused by the Coronavirus has been overwhelming and, in some cases, catastrophic. None of us could have anticipated that a virus could so quickly affect nearly every aspect of our personal and business lives.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">All of us are heartbroken for anyone who's been impacted by this pandemic, either directly or indirectly, and our hope is for a speedy recovery. We applaud the healthcare workers on the front lines caring for people who need treatment. During this challenging time, I want to let you know how we are approaching the situation at BIO-key.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Operations</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">To ensure the safety for all our employees, BIO-key has transitioned to a nearly 100% remote work-from-home model. To maintain a seamless business operation, we are conducting daily conference calls with our executive team, as well as sales, support and marketing departments. From an execution standpoint, we&#8217;ve made the appropriate adjustments to conduct business as effectively as possible given the circumstances.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Product Development, Support and Fulfillment</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Our R&amp;D and product development teams remain engaged in their efforts and are in constant communication to keep our innovation moving forward. Our support team is responding to help BIO-key customers make the shift to remote workforces using our biometric MFA technology to make that transition as seamless as possible. To fulfill orders, BIO-key has enough hardware inventory to meet expected demand and we obviously have unlimited software capacity with online download of new orders and updates.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>BIO-key Solutions Match the new Remote Workforce Model</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The new remote workforce model being adopted across most industries presents a new range of security and authentication challenges that can be cost-effectively addressed by our solutions. Our online biometric single sign-on (SSO) and enterprise class multi-factor authentication (MFA) solutions operate equally well in on-premise or remote work environments and provide assurance that only the right user can access sensitive systems remotely. Long before the current crisis, BIO-key solutions have been proven to provide best-in-class remote cybersecurity solutions for government agencies, law enforcement, financial services, education, retail, manufacturing and the Fortune 500.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Business / Investor Update</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Despite current challenges posed by the global pandemic and its human and economic impact, BIO-key&#8217;s business strategy has gained significant momentum internationally, particularly in Africa, as highlighted by recent developments:</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">$45 million contract to provide biometric solutions in support of a Nigerian Ministry of Labour program to educate, empower and create employment for one million recent college graduates in Nigeria.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">$30 million contract to facilitate the enrollment and positive identification of millions of customers for Nigerian mobile telecommunications company.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">Expansion of the use of BIO-key solutions by the Dubai Police Force.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">Expanding footprint of BIO-key solutions being used to secure access election data in Florida.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">A major expansion by our customer ICU Medical to enable remote learning.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">&#9679;</p>
			</td>
			<td style="padding-bottom: 5px;">
			<p style="font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">A growing footprint securing election offices across the U.S.</p>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">BIO-key will provide further updates on its progress via press releases and its normal quarterly investor conference calls. Visit <u>www.bio-key.com</u> for more information and/or email <u>bkyi@catalyst-ir.com</u> to be added to the Company&#8217;s investor email list.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Outlook for Biometric Adoption</b></p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Though change remains a constant in our personal and business lives, we can always be identified by our biometric. As such, biometrics can play a valuable role in traditional work environments and an even greater one in remote environments. Our biometric solutions allow users to move beyond the challenges and limitations of mainstream authentication methods, such as passwords, tokens and pins, while delivering improved ease of use, lower costs, increased worker efficiency and providing critical auditing capabilities.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">With the growing proliferation of online assets, the new remote workforce model, and hackers and cyberthieves looking to thrive upon vulnerabilities within this new landscape, we believe BIO-key solutions are becoming increasingly recognized as valuable security differentiators for our partners and customers.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We stand by to support our partners and customers in any way we can and wish you all good health and success in navigating current challenges.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Sincerely,</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Michael DePasquale&nbsp;</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Chairman &amp; CEO</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>About BIO-key International, Inc. (</b><u><b>www.bio-key.com</b></u><b>)</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">BIO-key is revolutionizing authentication and identity access management with <u><b>biometric solutions</b></u> that enable convenient and secure access to information and high-stakes transactions. We offer software-based alternatives to passwords, PINs, tokens, and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium <u><b>finger scanning devices</b></u> offer market-leading quality, performance and price &#8211; providing more ways to BIO-key your world!</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>BIO-key Safe Harbor Statement</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">BIO-key Safe Harbor Statement All statements contained in this&nbsp;press release&nbsp;other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to raise additional capital, our ability to protect our intellectual property, market acceptance of biometric products generally and our products under development, our ability to expand into Asia, Africa and other foreign markets, changes in business conditions, changes in our sales strategy and product development plans, changes in the marketplace, continued services of our executive management team, security breaches, competition between us and other companies in the biometric technology industry, delays in the development of products and statements of assumption underlying any of the foregoing. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., please see the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our company in particular have been material, are changing rapidly, and cannot be predicted.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><b>Facebook &#8211; Corporate:</b><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><u><b>BIO-key International</b></u><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><b>Twitter &#8211; Corporate:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b><u><b>@BIOkeyIntl</b></u><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><b>Twitter &#8211; Investors:</b> &nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp; <u><b>@BIO_keyIR</b></u><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><b>StockTwits:</b>&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; <u><b>BIO_keyIR</b></u><b><u>&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><b>Investor &amp; Media Contacts</b></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;">William Jones, David Collins</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;">Catalyst IR</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;">212-924-9800</p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;"><u><b>bkyi@catalyst-ir.com</b></u></p>

<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;">&nbsp;</p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex_180384img001.jpg
<TEXT>
begin 644 ex_180384img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  W -T# 2(  A$! Q$!_\0
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M/9W<30S1M_$K#!KY+\0? ^T^'Y;4->^(&GVNB,YP'@8W3#L(T!.]L<=AWK[
MKQC]H3X??\);X&_MS3X-^KZ(&F0*/FE@/^L3\AN'T]ZY<134XWM=H]7+<5.C
M548SY4]_Z9\YWWCJ7[)-HOP]L)/#^ER I/J$C;KZ\7_;D'W%/]Q,>YKF;6P@
MM1N4;Y.[MUINFW*W%FHXW)P0/T-7:\&4W+<_1J%"G!<RU;Z]0KTKX&37D?Q?
MTY+4MLEAF6<#H8]F>?Q"URGA;P;XB\9:C]CT&P:?:<23M\L4/^\W].OM7U7\
M-?A;IO@"VEN6N/M^L7*!)KDKM55Z[$'89[]3@5TX6C.4U);(\S.,?1HT)T6[
MRDK6]>YZ)7D'[1\WE? _45_YZ7-NG_D0'^E>OUYO\9_!>M^/OA^OA_09+6.X
M-Y',YN7*+L4-GD \Y(KVZB;@TCX+!RC'$0E)V2:-'X2Q^5\&O":?]0^(_F,U
MQG[2&AZ'=_":ZUB\MX5U*SFB^RW&T"0LS@%,]2"">/;/:LS2/#G[1NAZ)9:-
MIVL>%4L[*%8(59&8A5&!D[.:JWWP9^)7C_4K63XG>.;9M.MVW"RTV,@>^.%4
M$CC<0QK)MN'*HG?3C"GB/;RJJR=]+M^FQT7AO6]0U']DQ]5U25Y;K^Q;E#*Y
MRSA0Z*Q/<D <UF_LM1[?A+>/_>U27](XQ7H_B;PF;CX3:CX+\,PPVN_3S96B
M2,51!MP,G!/XUC?!?P/K'P_\ 2:%K<EM)=M>R7&;9RZ[6"@<D#GBJ46IKR1E
M*M3EAZB6CE*Z7D>/>"[R/X:?M4>(-%UEA;6>MLZP32<+^\?S(CGT)W+]:^JJ
MX#XE?"OP_P#$K38DU O9ZE; BVOX0"\8/\+#^)?;\B*\[L?#7[1W@^!=-T?Q
M#H_B*PB&V(WI^=5[#+ -^&XTH\U.ZM=%573QBC/G49I)-/K;JF?03,%4LQ"@
M#))XQ7RS:W"_%/\ :XAU/2SY^C>'@K?:%Y0K%G!!_P!J5N/4#-=%?>"/C[X\
MA.F^+/%6F:!I$G$T.GC+2+W'R\GZ%L5ZQX#^'_A_X>>'_P"R=#A8M(0]Q<R\
MRW#^K'T'8#@4/FJ-:60H.GA(2:DI3:LK;*^[N>4ZS\ ?'>J:_J.I6_QY\1V,
M-W<R3I;1"39 K,2$7$HX .!P.E1>+?!.M?#O]F#XAV>N>.-1\7375LSI<7^[
M="I"IL&7;C//7O7T17!_&#PIK'CCX0Z]X4T%[=-0U&...-KERD8 D5FR0">B
MGM70>2?(FG?#K7+'X&?#WXW>#X?M^J^'5EFN]/N!YL<D*7$A$B(>FWG<!SCY
MA@CG[&^&_P 0]"^)O@BT\3Z')A9!LN+9CE[68?>C;Z=CW!![U6^$?A#4? _P
M?T#PCK36\E]80O'.8&+QDM(S<$@9&&':O,](^#GC+X;_ !SN?%'PSN-._P"$
M.U<AM2T:ZG:/9D_-Y0"D?*267IC)7I0!Y1XC\)>&_$W[>FJ>'?'MNTVFZK"K
M6R><T6]_LRE,,I!ZJPQGK7M__#*OP3_Z%FY_\&-Q_P#%U-\;/@5;?%%[#7M'
MU8Z%XLTP 6U\ =KJ&W*K[>1@Y(8<C)X-<G8C]L'2;1=->+PGK)C&Q;^X?#L!
MW."F3_P&@#TKP7\#/AK\/_$8\0^%M$EM-1$30^:]W++\K8R,,Q'85XU\:XV^
M&O[47@/XJP QZ?JC#3]18=./W;$_]LW!_P"V=>W_  OTWXGV>EZC<_%+6['4
M-2NIE:WAL% BM8@OW?NKDDY)Z]N:Y/\ :DT+3M9_9[UNXOIX[>72WBO;:1_^
M>@8+M'NP=E'N10!Y_P#&%7^+W[2_A3X1VS&31M#']I:QM/'(#%3_ , VJ/>4
MU]51HD4:QQH$1 %55&  .@%?-_[)WA+4(_".I_$SQ'))<ZWXGE^2>;[YMT.
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M6-M)="&,,GGHG!,;, KC.!E20,BMD>(-'^RM<-?1JBW0LF/)VSE@OE_7<0*
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MOS$9+@L>I+AV/7@[?2JTOP^\27^DBRU'6[!?L^B2:/;?9[9P,L8B)7RV>1$
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79?[4N8YE4+@QA84CP3W^X3^-%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
